Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

97.02 

1.45 1.5%

as of Oct 11 '19

52 Week Range:

95.10 219.99


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. The company sells its products through various channels, including the Internet, call centers, independent health advisors, franchise weight loss clinics, and direct consumer marketing. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 2.66
3.30
4.66
4.61
6.59
8.49
6.84
7.35
8.00
9.04
9.41
growth rate 24.1% 41.2% -1.1% 43.0% 28.8% -19.4% 7.5% 8.8% 13.0% 4.1%
Earnings BIT 7.85
19.29
31.69
27.68
24.46
34.19
34.84
30.77
34.11
39.63
69.06
growth rate 145.7% 64.3% -12.7% -11.6% 39.8% 1.9% -11.7% 10.9% 16.2% 74.3%
Avg.PE 14.56
37.74
21.46
10.50
22.83
15.06
30.02
27.15
28.72
41.97
28.46
growth rate 159.2% -43.1% -51.1% 117.4% -34.0% 99.3% -9.6% 5.8% 46.1% -32.2%
ROA 11.47
21.03
25.01
18.57
13.46
18.23
10.61
17.20
14.95
20.75
35.38
growth rate 83.4% 18.9% -25.8% -27.5% 35.4% -41.8% 62.1% -13.1% 38.8% 70.5%
ROE 15.40
27.27
32.27
25.51
19.34
25.34
14.74
23.73
19.32
27.10
51.26
growth rate 77.1% 18.3% -21.0% -24.2% 31.0% -41.8% 61.0% -18.6% 40.3% 89.2%
ROIC 12.82
23.51
29.11
23.37
18.00
24.32
14.11
23.15
19.12
26.72
51.26
growth rate 83.4% 23.8% -19.7% -23.0% 35.1% -42.0% 64.1% -17.4% 39.8% 91.8%
Cur. Ratio 2.48
5.61
3.80
3.16
3.08
3.39
3.04
3.74
4.15
3.37
2.41
growth rate 126.2% -32.3% -16.8% -2.5% 10.1% -10.3% 23.0% 11.0% -18.8% -28.5%
Quick Ratio 0.42
2.75
2.20
1.74
2.16
2.55
2.02
2.92
3.20
2.68
1.69
growth rate 554.8% -20.0% -20.9% 24.1% 18.1% -20.8% 44.6% 9.6% -16.3% -36.9%
Leverage 1.33
1.27
1.31
1.44
1.43
1.35
1.44
1.32
1.26
1.34
1.55
growth rate -4.5% 3.2% 9.9% -0.7% -5.6% 6.7% -8.3% -4.6% 6.4% 15.7%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 0.40
0.70
0.60
2.53
3.61
2.90
1.65
1.63
1.39
0.58
1.01
growth rate 75.0% -14.3% 322.0% 42.5% -19.7% -43.1% -1.0% -15.1% -58.5% 75.5%
Acct.Payable 18.83
28.22
22.33
12.18
11.26
9.58
13.80
21.81
growth rate 49.9% -20.9% -45.5% -7.5% -15.0% 44.0% 58.1%
Cur.Assets 21.50
35.60
60.70
63.99
88.58
91.95
81.91
86.87
101.30
125.20
145.52
growth rate 65.6% 70.5% 5.4% 38.4% 3.8% -10.9% 6.0% 16.6% 23.6% 16.2%
Total Assets 50.30
63.00
94.10
105.67
130.25
132.65
115.91
116.12
121.22
145.93
169.43
growth rate 25.3% 49.4% 12.3% 23.3% 1.8% -12.6% 0.2% 4.4% 20.4% 16.1%
Cash 1.80
10.60
17.20
14.26
39.94
36.38
24.46
42.04
52.44
75.08
81.36
growth rate 488.9% 62.3% -17.1% 180.0% -8.9% -32.8% 71.9% 24.7% 43.2% 8.4%
Inventory 13.90
11.20
19.50
19.97
20.80
17.54
15.74
13.34
18.31
19.33
38.89
growth rate -19.4% 74.1% 2.4% 4.2% -15.7% -10.3% -15.3% 37.3% 5.6% 101.2%
Cur.Liabilities 8.90
8.50
16.00
20.26
28.75
27.10
26.94
23.56
24.42
37.14
60.32
growth rate -4.5% 88.2% 26.6% 41.9% -5.7% -0.6% -12.5% 3.6% 52.1% 62.4%
Liabilities 15.10
15.10
22.10
32.26
39.47
34.23
35.43
27.53
25.20
37.35
60.32
growth rate 0.0% 46.4% 46.0% 22.3% -13.3% 3.5% -22.3% -8.5% 48.2% 61.5%
LT Debt 4.30
5.40
4.90
4.25
3.81
0.47
0.24
growth rate 25.6% -9.3% -13.2% -10.4% -87.6% -49.0%
Equity 35.20
47.80
72.00
73.40
90.79
98.42
80.48
88.58
96.02
108.58
109.11
growth rate 35.8% 50.6% 2.0% 23.7% 8.4% -18.2% 10.1% 8.4% 13.1% 0.5%
Common Shares 14.00
15.00
15.00
14.00
14.00
14.00
13.00
12.00
12.00
12.00
12.00
growth rate 7.1% 0.0% -6.7% 0.0% 0.0% -7.1% -7.7% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 7.40
5.10
12.10
14.27
8.13
11.39
7.02
2.82
2.88
3.24
4.94
growth rate -31.1% 137.3% 18.0% -43.1% 40.1% -38.3% -59.9% 2.0% 12.7% 52.4%
Cash Dividends 0.00
0.00
0.00
0.00
0.00
11.89
11.89
11.89
15.39
23.16
growth rate 0.0% 0.0% 29.5% 50.5%
Cash From OA 5.50
19.20
28.80
34.87
40.26
42.36
25.54
29.41
25.35
43.24
60.82
growth rate 249.1% 50.0% 21.1% 15.5% 5.2% -39.7% 15.2% -13.8% 70.6% 40.7%
FCF per Share -0.14
1.02
1.15
1.45
2.10
1.59
1.96
1.96
2.05
2.47
4.24
growth rate 100.0% 12.8% 26.1% 44.8% -24.3% 23.3% 0.0% 4.6% 20.5% 71.7%
Sale Purchase of Stock -20.39
-2.76
-20.08
0.04
0.04
0.30
0.57
growth rate 0.0% 0.0% 100.0% 0.0% 579.6% 90.0%
FCF -2.00
15.00
17.00
20.00
29.00
31.00
19.00
27.00
22.00
40.00
56.00
growth rate 100.0% 13.3% 17.7% 45.0% 6.9% -38.7% 42.1% -18.5% 81.8% 40.0%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 105.40
169.70
257.60
298.19
318.57
324.05
285.29
272.77
274.53
301.56
501.00
growth rate 61.0% 51.8% 15.8% 6.8% 1.7% -12.0% -4.4% 0.7% 9.9% 66.1%
Op.Income 8.20
18.50
31.60
18.54
18.44
27.14
34.84
30.77
34.11
39.63
69.06
growth rate 125.6% 70.8% -41.3% -0.5% 47.1% 28.4% -11.7% 10.9% 16.2% 74.3%
IBT 7.90
18.40
31.70
27.68
28.36
39.04
31.69
29.67
27.12
40.33
70.55
growth rate 132.9% 72.3% -12.7% 2.4% 37.7% -18.8% -6.4% -8.6% 48.7% 74.9%
Net Income 4.80
11.40
19.60
18.54
18.44
27.14
13.18
20.06
17.84
27.72
55.79
growth rate 137.5% 71.9% -5.4% -0.5% 47.1% -51.4% 52.2% -11.1% 55.4% 101.3%
EPS 0.34
0.77
1.35
1.31
1.16
1.73
1.03
1.66
1.49
2.29
4.62
growth rate 126.5% 75.3% -3.0% -11.5% 49.1% -40.5% 61.2% -10.2% 53.7% 101.8%
Gross Profit 80.10
124.40
192.50
224.50
235.91
240.57
209.21
201.32
205.66
227.81
379.90
growth rate 55.3% 54.7% 16.6% 5.1% 2.0% -13.0% -3.8% 2.2% 10.8% 66.8%
R&D 1.30
1.80
2.00
1.50
growth rate 38.5% 11.1% -25.0%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 17.11
17.47
19.80
24.72
27.36
growth rate 2.1% 13.4% 24.8% 10.7%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 0.93
1.02
1.01
0.63
0.98
growth rate 8.9% -0.6% -37.6% 55.0%
Acct.Payable 53.44
62.81
21.81
74.45
73.57
growth rate 17.5% -65.3% 241.3% -1.2%
Cur.Assets 135.09
151.93
145.52
169.31
171.98
growth rate 12.5% -4.2% 16.4% 1.6%
Total Assets 156.31
174.45
169.43
210.07
212.57
growth rate 11.6% -2.9% 24.0% 1.2%
Cash 81.08
82.31
81.36
101.84
96.31
growth rate 1.5% -1.2% 25.2% -5.4%
Inventory 26.90
43.85
38.89
43.26
48.47
growth rate 63.0% -11.3% 11.2% 12.1%
Cur.Liabilities 53.44
62.81
60.32
76.90
76.04
growth rate 17.5% -4.0% 27.5% -1.1%
Liabilities 53.44
62.81
60.32
88.00
86.55
growth rate 17.5% -4.0% 45.9% -1.7%
LT Debt 11.11
growth rate
Equity 102.86
111.64
109.11
122.07
126.02
growth rate 8.5% -2.3% 11.9% 3.2%
Common Shares 0.01
0.01
0.01
0.01
0.01
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 0.81
1.15
1.69
4.44
2.53
growth rate 42.6% 47.1% 162.3% -43.1%
Cash Dividends 5.79
5.73
5.76
8.83
8.92
growth rate -1.0% 0.4% 53.3% 1.1%
Cash From OA 20.52
6.95
15.34
32.73
14.48
growth rate -66.2% 120.8% 113.4% -55.8%
Sale Purchase of Stock
growth rate
FCF 19.72
5.80
13.64
28.29
11.95
growth rate -70.6% 135.4% 107.3% -57.8%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 117.32
139.24
145.84
165.88
187.10
growth rate 18.7% 4.7% 13.7% 12.8%
Op.Income 17.11
17.47
19.80
24.72
27.36
growth rate 2.1% 13.4% 24.8% 10.7%
IBT 17.62
17.83
20.17
25.02
27.78
growth rate 1.2% 13.1% 24.1% 11.0%
Net Income 14.13
13.78
15.65
20.75
21.38
growth rate -2.5% 13.6% 32.6% 3.1%
EPS
growth rate
Gross Profit 88.80
107.20
109.09
125.15
140.71
growth rate 20.7% 1.8% 14.7% 12.4%
R&D 0.56
0.62
-1.60
0.65
0.55
growth rate 10.7% -100.0% 100.0% -16.1%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (86.40)

YOY Growth Grade:

C (56.65)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 16.42 16.42 11.41
EPS / Growth 7.7% 5.91 15.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 6.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.0% 9.6% 9.6%
Future PE 11.41 15.65 15.65
Future EPS 10.59 14.72 14.72
Value Price
MOS %
29.88
-69.2%
56.97
-41.3%
56.97
-41.3%
MOS Price 14.94 28.48 28.48
IRT 11.27 9.73 9.73

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.